Navigation Links
Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference
Date:11/27/2013

cell activating factor, or BAFF, which has been associated with a variety of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), or lupus, Immunoglobin A nephropathy, or IgAN, lupus nephritis, vasculitis, rheumatoid arthritis, idiopathic thrombocytopenia purpura, and others.

Safe Harbor Statement

Any statements contained in this press release that refer to future events or other non-historical matters, including statements that are preceded by, followed by, or that include such words as "estimate," "intend," "anticipate," "believe," "plan," "goal," "expect," "project," or similar statements, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on Anthera's expectations as of the date of this press release and are subject to certain risks and uncertainties that could cause actual results to differ materially as set forth in Anthera's public filings with the SEC, including Anthera's Annual Report on Form 10-K for the year ended December 31, 2012.  Anthera disclaims any intent or obligation to update any forward-looking statements, whether because of new information, future events or otherwise, except as required by applicable law.

CONTACT: Dennis Lutz of Anthera Pharmaceuticals, Inc., dlutz@anthera.com or 510.856.5598.


'/>"/>
SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Anthera Pharmaceuticals Reports 2013 Third Quarter Financial Results, Clinical and Regulatory Update
2. Anthera Pharmaceuticals Announces Emerging Data from Phase 2 Open-Label Extension Study to be Presented at the ACR/ARHP 2013 Annual Scientific Meeting
3. Anthera Pharmaceuticals Reports 2013 Second Quarter Financial Results
4. Anthera Announces Initiation of BRIGHT-SC Phase 2 Clinical Study in IgA Nephropathy with Blisibimod
5. Anthera Pharmaceuticals Announces Receipt of Nasdaq Notice
6. Anthera Pharmaceuticals Announces Personnel Changes
7. Anthera Pharmaceuticals to Present at Annual Jefferies Healthcare Conference
8. Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
9. Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study
10. Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
11. Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 25, 2014 Halozyme Therapeutics, Inc. ... Piper Jaffray Healthcare Conference in New York ... a.m. PDT . Dr. Helen Torley , President ... The presentation will be webcast through the "Investors" section ... recording will be made available for 90 days following the ...
(Date:11/24/2014)... 24, 2014 Juno Therapeutics today announced ... to the company,s JCAR015 chimeric antigen receptor product ... relapsed or refractory B-cell acute lymphoblastic leukemia and ... Kettering Cancer Center, where Phase 1 clinical trials ... action is important news for patients who may ...
(Date:11/24/2014)... , Nov. 24, 2014 The Female Health ... an investor conference call to discuss its operating results ... 30, 2014 on Tuesday, December 2, 2014 at 11:00 ... report its operating results earlier the same day. ... the conference call by dialing 1-877-374-8416 (international participants dial ...
Breaking Medicine Technology:Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 2Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 3The Female Health Company To Report FY2014 Operating Results on Tuesday, December 2, 2014 2
... NEW YORK, May 4, 2011 ... research report is available in its ... for Orthopedic Biomaterials 2011 – Bone ... Countries) http://www.reportlinker.com/p0488653/European-Markets-for-Orthopedic-Biomaterials-2011-–-Bone-Grafting-and-Hyaluronic-Acid-Viscosupplementation-15-Countries.html ...
... May 4, 2011 To provide pain management ... tools to help address practice challenges, Millennium ... monitoring services, is funding educational grants for a ... in the series, ",MAD, Misuse–Addiction–Diversion, Proactive Approaches for ...
Cached Medicine Technology:Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 2Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 3Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 4Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 5Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 6Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 7Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 8Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 9Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 10Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 11Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 12Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 13Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 14Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 15Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 16Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 17Reportlinker Adds European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries) 18Millennium Laboratories Launches New Educational Webinar Series for Pain Management Physicians 2Millennium Laboratories Launches New Educational Webinar Series for Pain Management Physicians 3Millennium Laboratories Launches New Educational Webinar Series for Pain Management Physicians 4
(Date:11/26/2014)... Sonru, the video interviewing specialist, has today ... and Chief Marketing Officer, in addition to the formal ... Jones has been appointed as Chief Operating Officer. He ... of Chief Marketing Officer. , Mr Jones is a ... includes senior roles with The Walt Disney Company and ...
(Date:11/26/2014)... Call 866-997-4948 (Us-Canada Toll Free) Tel: ... details on sales(at)researchmoz(dot)us , Researchmoz.us announces a new ... 2014" with deep study of the report on the ... blood sugar. The global glucose monitoring market has a ... number of diabetics in the world. Their numbers have ...
(Date:11/26/2014)... For those with a New Year’s resolution ... BODYPUMP™ classes at the University of Colorado Anschutz Health ... looking for. The 45- 60 minute classes have just started ... Center fitness club memberships. , LES MILLS BODYPUMP™ exercise classes ... are aimed at fast results , By focusing on ...
(Date:11/26/2014)... November 26, 2014 Sonoran Vein ... recently received the Distinguished Preceptorship Award from ... her role in the advancement of nurse practitioners. ... an individual who had made a significant contribution ... The American Association of Nurse Practitioners (AANP) is ...
(Date:11/26/2014)... Nov. 25, 2014 (HealthDay News) -- Vultures have developed ... they ingest when eating dead animals, researchers report. ... found on the faces and in the guts of ... States. On average, the faces of the vultures had ... 76 in their guts, the study found. The ...
Breaking Medicine News(10 mins):Health News:Sonru Expansion continues with appointment of new executive team and opening of new London base 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:LES MILLS BODYPUMP™ classes come to the University of Colorado Anschutz Health and Wellness Center 2Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2
... WASHINGTON, May 15 A new report, funded and ... 1,500 drug codes from its,CY 2008 Part D Formulary ... these drugs from their Medicare offerings in 2008,resulting in ... The CMS action was driven in part to remove ...
... Men Employees Hold Large Companies to a Higher Standard with ... Mandatory Healthcare ... women (58%) were more likely than men (47%) to find paying,for healthcare ... likely than men (42%) to have done some retirement,healthcare planning., Gender ...
... identified hundreds of genes involved in the development of cancer ... find the cancer causing mutations. , The study found ... 350 regions in the mouse genome in cancer formation. 50 ... in human cancers while the other regions were novel, adding ...
... to Raise Money for HIV ... Services in Tri-State Area, NEW YORK, May 15 Duane ... donate $50,000 as,a Grand-level sponsor of AIDS Walk New York, which ... programs and,services in the tri-state area. Since 1986, the annual walk ...
... real-world problems ... in radiology, BOSTON, May ... medical image and information management solutions,today announced that its complete suite of ... 2008,Annual Meeting in Seattle, WA, from May 15 to 18. AMICAS will ...
... Vendormate, Inc., the leading provider,of business-credentialing ... from risky vendors, completes its tenure at,Georgia ... ATDC is a,nationally-recognized science and technology incubator ... companies., ATDC provides strategic business advice ...
Cached Medicine News:Health News:Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File 2Health News:Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File 3Health News:Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File 4Health News:Guardian Survey: Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement 2Health News:Guardian Survey: Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement 3Health News:Guardian Survey: Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement 4Health News:Guardian Survey: Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement 5Health News:Connecting cancer genes 2Health News:Duane Reade Announces Proud Sponsorship of AIDS Walk New York 2Health News:AMICAS Focuses on the Future of Radiology IT at SIIM 2008 2Health News:AMICAS Focuses on the Future of Radiology IT at SIIM 2008 3Health News:Vendormate Graduates ATDC Technology Incubator Program 2
... Plastic and fabric specialty drapes for use ... creates a barrier to inhibit fluid strike-through, ... other drape or towel layers, saving time ... inch (60cm x 90cm) Urological Drape, Clear ...
... the Penilab IV and the Penilab V have an ... Model 1060 is similar to the Model 1061 shown ... one be added later. The Penilab V has ... of the accessories you'll need to get started. ...
... The portable NEVA™ System is ... volumetric changes within the penis ... used to monitor and record ... to changes in penile blood ...
The Model 240 is a single-channel instrument designed for penile tumescence monitoring. It features exceptional stability. It's ready for use with most multi-channel recorders having a DC input....
Medicine Products: